MAPT and Alzheimer disease: The detection of significant changes in CSF NSE levels in both AD and DLB reminds us that AD and DLB share common amyloid β- and tau-related pathologies [35], but examining the effects of these pathologies on CSF NSE levels would require further studies, such as studies involving amyloid or tau PET.